Predicting survival and the role of androgen suppressive therapy (AST): Radiation therapy oncology group (RTOG) phase III randomized prostate cancer trials
- 31 December 1998
- journal article
- abstracts
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 42 (1) , 177
- https://doi.org/10.1016/s0360-3016(98)80207-1
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: